SeaStar Medical (NASDAQ:ICU) Announces Quarterly Earnings Results

SeaStar Medical (NASDAQ:ICU) issued its quarterly earnings data on Thursday. The company reported ($0.90) earnings per share (EPS) for the quarter, Zacks reports.

SeaStar Medical Price Performance

ICU stock traded down $0.23 during trading on Thursday, reaching $2.20. 346,809 shares of the stock traded hands, compared to its average volume of 250,448. The firm has a market capitalization of $14.24 million, a PE ratio of -0.19 and a beta of -0.97. The business’s 50 day moving average price is $1.86 and its 200-day moving average price is $2.65. SeaStar Medical has a 52-week low of $1.50 and a 52-week high of $20.70.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.